Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
7.28
-0.55 (-7.02%)
At close: Feb 21, 2025, 4:00 PM
7.38
+0.10 (1.37%)
After-hours: Feb 21, 2025, 5:41 PM EST
Verve Therapeutics Employees
Verve Therapeutics had 255 employees as of December 31, 2023. The number of employees increased by 51 or 25.00% compared to the previous year.
Employees
255
Change (1Y)
51
Growth (1Y)
25.00%
Revenue / Employee
$95,671
Profits / Employee
-$772,651
Market Cap
616.35M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 255 | 51 | 25.00% |
| Dec 31, 2022 | 204 | 91 | 80.53% |
| Dec 31, 2021 | 113 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
VERV News
- 19 days ago - Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 22 days ago - Kuehn Law Encourages Investors of Verve Therapeutics, Inc. to Contact Law Firm - PRNewsWire
- 24 days ago - Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewsWire
- 27 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Verve Therapeutics, Inc. (VERV) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 4 weeks ago - Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 4 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Shareholders to Inquire about Securities Investigation - Accesswire
- 5 weeks ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Verve Therapeutics, Inc. (VERV) And Encourages Shareholders to Connect - Accesswire
- 5 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Stockholders to Inquire about Securities Investigation - Accesswire